Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 10, 2020

SELL
$25.95 - $43.15 $5,112 - $8,500
-197 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$60.18 - $154.77 $9,929 - $25,537
165 Added 515.63%
197 $14,000
Q3 2019

Oct 18, 2019

BUY
$140.29 - $189.96 $4,489 - $6,078
32 New
32 $4,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.